These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 90787)

  • 1. Defects of immune interferon secretion and natural killer activity in patients with immunological disorders.
    Virelizier JL; Lipinski M; Tursz T; Griscelli C
    Lancet; 1979 Sep; 2(8144):696-7. PubMed ID: 90787
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
    Katz P; Zaytoun AM; Lee JH; Fauci AS
    J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered lectin-mediated cytotoxicity in Chédiak-Higashi syndrome patients.
    Merino F; Rodríguez F; Biondo-Bracho M; Amesty C; Ramírez-Duque P
    Clin Immunol Immunopathol; 1984 Nov; 33(2):139-43. PubMed ID: 6333304
    [No Abstract]   [Full Text] [Related]  

  • 5. Chediak-Higashi syndrome natural killer cells: a protein kinase C defective activation/regulation defect?
    Merino F; Esparza B; Sabino E
    Eur J Pediatr; 1996 Mar; 155(3):254. PubMed ID: 8929738
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interferon and natural killer cells].
    Saksela E
    Duodecim; 1980; 96(16):1061-4. PubMed ID: 6164530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chediak-Higashi syndrome in an adult female].
    Utsunomiya A; Saito T; Hanada S; Tin E; Oshige T; Hashimoto S; Hamaguchi Y; Ueno T
    Rinsho Ketsueki; 1988 Sep; 29(9):1422-6. PubMed ID: 3216514
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural killer cell activity in a patient with Chédiak-Higashi syndrome submitted to bone marrow transplantation.
    Diamond HR; Souza MH; Silva ML; Tabak DG; Ferman S; M-Silva VM; de La Rocque L; Rumjanek VM
    Pediatr Hematol Oncol; 1995; 12(4):399-402. PubMed ID: 7577393
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a murine model (beige) for a natural killer cell immunodeficiency in the Chediak-Higashi syndrome of man.
    Roder JC
    Prog Clin Biol Res; 1982; 94():315-25. PubMed ID: 7122620
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of natural killer defect in a patient with Chédiak-Higashi syndrome after bone-marrow transplantation.
    Virelizier JL; Lagrue A; Durandy A; Arenzana F; Oury C; Griscelli C; Reinert P
    N Engl J Med; 1982 Apr; 306(17):1055-6. PubMed ID: 7038504
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural killer cells.
    Kay NE
    Crit Rev Clin Lab Sci; 1986; 22(4):343-59. PubMed ID: 2419034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of natural killer cell hyporesponsiveness in the Chediak-Higashi syndrome.
    Brahmi Z
    Hum Immunol; 1983 Jan; 6(1):45-52. PubMed ID: 6219972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of natural killer cell activity].
    Abo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2-induced cytotoxicity of Chediak-Higashi lymphocytes.
    Holcombe RF
    Acta Haematol; 1992; 87(1-2):45-8. PubMed ID: 1533985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chédiak-Higashi gene in humans I. Impairment of natural-killer function.
    Haliotis T; Roder J; Klein M; Ortaldo J; Fauci AS; Herberman RB
    J Exp Med; 1980 May; 151(5):1039-48. PubMed ID: 6154765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "lazy" NK cells of Chediak-Higashi syndrome.
    Targan SR; Oseas R
    J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T gamma cells in Chediak-Higashi syndrome.
    van de Griend RJ; Astaldi A; de Bruin HG; Weening RS
    N Engl J Med; 1982 Jun; 306(22):1368-9. PubMed ID: 6978462
    [No Abstract]   [Full Text] [Related]  

  • 19. Chediak-Higashi syndrome: immunological responses to Epstein-Barr virus studies in gene heterozygotes.
    Merino F; Amesty C; Henle W; Layrisse Z; Bianco N; Ramírez-Duque P
    J Clin Immunol; 1986 May; 6(3):242-8. PubMed ID: 3013924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.
    Abo T; Roder JC; Abo W; Cooper MD; Balch CM
    J Clin Invest; 1982 Jul; 70(1):193-7. PubMed ID: 7085883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.